Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 134 of 1,261
  1. US 11911359

    Stimulation of an immune response by cationic lipids

    PDS Biotechnology Corporation Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  2. US 11913883

    Highly specific tissue imaging

    The Board of Regents of the University of Texas System Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  3. US 11912780

    Anti-CD45-based conditioning methods and uses thereof in conjunction with gene-edited cell-based therapies

    Actinium Phamaceuticals, Inc. Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  4. US 11912997

    RNAi agents for inhibiting expression of Superoxide Dismutase 1 (SOD1), compositions thereof, and methods of use

    Arrowhead Pharmaceuticals, Inc. Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  5. US 11912682

    Isoindolinone compounds

    Monte Rosa Therapeutics AG Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  6. US 11912750

    GDNF fusion polypeptides and methods of use thereof

    Keros Therapeutics, Inc. Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  7. US 11913012

    Cardiac cell reprogramming with myocardin and ASCL1

    Tenaya Therapeutics, Inc. Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  8. US 11911464

    Anti-parasitic immunological compositions

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  9. US 11911482

    Self assembling protein nanoparticles as carrier molecules

    The Regents of the University of California Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  10. US 11912762

    Method of treating osteoarthritis by administering an anti-connexin 43 antibody

    The Board of Regents of the University of Texas System Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  11. US 11911345

    Phage dispensing system

    Adaptive Phage Therapeutics, Inc. Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  12. US 11911376

    Methods for preventing and treating retinal damage

    The Regents of the University of Colorado Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  13. US 11911484

    Muscle targeting complexes and uses thereof for treating myotonic dystrophy

    Dyne Therapeutics, Inc. Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  14. US 11911367

    Methods for treating cancer

    Regents of the University of Minnesota Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  15. US 11911385

    Methotrexate treatment methods

    Aldeyra Therapeutics, Inc. Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  16. US 11911415

    CRISPR/Cas-related methods and compositions for improving transplantation

    Editas Medicine, Inc. Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  17. US 11912778

    Methods of engineering transferrin receptor binding polypeptides

    DENALI THERAPEUTICS INC. Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  18. US 11911419

    Compositions and methods for treating epilepsy and related disorders

    Finch Therapeutics Holdings LLC Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  19. US 11911446

    Use of C-type natriuretic peptide variants to treat skeletal dysplasia

    BIOMARIN PHARMACEUTICAL INC. Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  20. US 11912998

    Method of treating aging-associated cognitive impairment by reducing CCR3

    United States Government as represented by the Department of Veterans Affairs Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  21. US 11912695

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  22. US 11911435

    Stable antibody-drug conjugate, preparation method therefor, and use thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  23. US 11912758

    Methods of treating metastasis, including inhibiting bone cancer metastasis, by administering an antibody which binds connexin 43 (Cx43) hemichannel

    The Board of Regents of the University of Texas System Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted
  24. US 11913027

    Methods of treatment using pluripotent human adipose adult stem cells

    The Regents of the University of California Β· Granted Feb 27, 2024 Β· Expires Feb 22, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.